# Bipolar Disorder for NEET PG Psychiatry: Mania vs Hypomania, Bipolar I and II, Lithium Levels and Toxicity, Valproate, Lamotrigine, Pregnancy

Source: https://tracknation.in/story/bipolar-disorder-for-neet-pg-psychiatry-mania-vs-hypomania-bipolar-i-and-ii-lithium-levels-and-toxicity-valproate-lamotrigine-pregnancy (TrackNation — free UPSC notes with PYQs)

> NEET PG Psychiatry: bipolar I and II and cyclothymia, the criteria for mania and hypomania, causes of secondary mania, managing acute mania and bipolar depression, lithium levels, toxicity and monitoring, valproate, carbamazepine and lamotrigine, and drug risks in pregnancy, with a diagram, hooks, vignette MCQs and cards.

## Start Here

🎯 **Exam priority: High.** *Expect: mania ≥ 1 week vs hypomania ≥ 4 days, bipolar I vs II, cyclothymia (> 2 years), the symptom
list, drugs that cause mania, lithium target and toxic levels, drugs that raise lithium, lithium side effects and tests, valproate and carbamazepine
in pregnancy, lamotrigine rash, no antidepressant monotherapy, suicide risk.*

CBME mapping: **PS 6.1** — diagnose and manage an episode of mania. Lithium pharmacology is also in Pharmacology.

*Mood stabilisers compared; mania and hypomania rules; lithium levels and toxicity; bipolar treatment. Drawn by TrackNation.*

## Diagnosis

- Lifetime prevalence about 2.5% in men and 2.3% in women. **Bipolar I**: at least one **manic** episode (depression usually
too). **Bipolar II**: at least one major depressive episode and one **hypomanic** episode, never mania. **Cyclothymia**:
more than 2 years of hypomanic and depressive periods that never meet full criteria.

- **Manic episode**: elevated, expansive or irritable mood with increased energy for **≥ 1 week** (less if admitted) plus ≥ 3
symptoms (≥ 4 if only irritable): grandiosity, **decreased need for sleep**, pressured talk, flight of ideas, distractibility, increased
goal-directed activity, risky behaviour (spending sprees, bad investments, sexual indiscretion) — causing severe impairment, psychosis or
admission.

- **Hypomania**: the same picture for **≥ 4 days** with ≥ 3 symptoms but **no psychosis, no marked impairment and no
need for admission**; it can even be adaptive.

- Exclude causes of secondary mania: stimulants, corticosteroids, dopamine agonists, hyperthyroidism, phaeochromocytoma. Rapid cycling = ≥ 4
episodes a year. **15–20% die by suicide**.

## Treatment (MSD)

- **Severe mania**: a sedating second-generation antipsychotic, sometimes with lorazepam or clonazepam; IM haloperidol for extremely
hyperactive psychotic patients not eating or drinking; then lithium or an antiseizure mood stabiliser. Mood stabilisers include lithium,
valproate, carbamazepine, lamotrigine and SGAs (olanzapine, quetiapine, risperidone, aripiprazole, lurasidone).

- **Bipolar depression**: quetiapine (first line for bipolar II), lithium, lamotrigine, lurasidone, cariprazine. Antidepressants are
**not recommended alone**.

- **Maintenance** is indicated for all patients with bipolar I. Mixed episodes, rapid cycling, anxiety, substance use and neurological
disease predict relapse. Educate about the risks of manic sexual behaviour; light therapy can help seasonal bipolar depression.

## Mood Stabilisers

- **Lithium**: dampens mood swings, not normal mood; best response with a family history of typical bipolar disorder; takes 4–10 days
to work. Target **0.8–1.2 mEq/L** in acute mania; **toxic ≥ 1.5 mEq/L**. Common effects: fine tremor, nausea, diarrhoea, polyuria,
polydipsia, weight gain, worsened acne and psoriasis; longer term hypothyroidism, hypercalcaemia/hyperparathyroidism and renal damage. Toxicity:
gross tremor, brisk reflexes, headache, vomiting, confusion → seizures, arrhythmias; more likely in the elderly, renal impairment, sodium loss
(fever, vomiting, diarrhoea, diuretics) and with **thiazides, ACE inhibitors and NSAIDs**. Monitor lithium levels every 6 months and after dose
changes, TSH before starting, and renal function. Atenolol for severe tremor (propranolol may worsen depression).

- **Valproate**: acute mania and mixed states, wider window, no renal toxicity; nausea, sedation, weight gain; rarely
**hepatotoxicity and pancreatitis**. **Carbamazepine**: no loading dose; titrate to level.

- **Lamotrigine**: effective for bipolar depression and cycling; **rash and Stevens–Johnson syndrome**, especially with rapid
dose increases — report any rash, fever or mouth sores.

- **Pregnancy**: **valproate** is the most teratogenic (neural tube defects 1–4%) — avoid; carbamazepine also causes neural tube
defects (if continued, folate 4 mg daily); lithium is linked to **Ebstein anomaly** (low absolute risk; detailed second-trimester scan);
lamotrigine has the lowest risk of the group.

## Traps the Examiner Sets

- Mania 1 week; hypomania 4 days; any psychosis or admission makes it mania.

- One manic episode = bipolar I, even if depression never occurs.

- Thiazides, ACE inhibitors, NSAIDs and dehydration push lithium into the toxic range.

- No antidepressant alone in bipolar depression; no valproate in pregnancy.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **Mania 'DIG FAST': Distractibility, Indiscretion, Grandiosity, Flight of ideas, Activity up, Sleep need down, Talkative** — symptoms

- 🧠 **'Mania: a Week; Hypomania: four Days'** — duration

- 🧠 **Lithium raisers 'TAN': Thiazides, ACE inhibitors, NSAIDs** — interactions

- 🧠 **Pregnancy: 'Valproate → spine (NTD); Lithium → heart (Ebstein)'** — teratogens

- 🧠 **Lamotrigine: 'Low and slow, or the rash will show'** — lamotrigine

## Rapid-Revision Cards

- ≥ 1 manic episode.

- Hypomania + major depression; no mania.

- > 2 years subthreshold.

- ≥ 1 week + ≥ 3 symptoms; impairment/psychosis.

- ≥ 4 days; no psychosis or admission.

- Needs ≥ 4 symptoms.

- Steroids, stimulants, hyperthyroid.

- 15–20%.

- ≥ 4 episodes/year.

- Sedating SGA ± benzodiazepine.

- Quetiapine, lithium, lamotrigine.

- Never alone.

- 4–10 days.

- 0.8–1.2; toxic ≥ 1.5 mEq/L.

- Thiazides, ACE-I, NSAIDs, dehydration.

- Gross tremor, vomiting, confusion.

- Hypothyroid, hypercalcaemia, renal.

- Liver, pancreas; NTD 1–4%.

- No loading dose; NTD.

- Rash/SJS; bipolar depression.

- Ebstein anomaly.

## Sources

*Facts in this article were checked against these documents.*

- MSD Manual Professional: Bipolar Disorders; Medications for Treatment of Bipolar Disorders; Cyclothymic Disorder — Merck & Co. (MSD Manuals), reviewed 2025–26 (link)

- Lithium carbonate prescribing information — U.S. National Library of Medicine, DailyMed, 2026 (link)

- Competency Based Undergraduate Curriculum, Psychiatry (PS 6) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** Bipolar I disorder is defined by

- (a) at least one manic episode

- (b) at least one hypomanic and one depressive episode

- (c) 2 years of mild mood swings

- (d) recurrent depression only

**Answer: (a)** — Depression usually also occurs.

**Q2.** Bipolar II disorder requires

- (a) at least one major depressive episode and one hypomanic episode, with no mania

- (b) one manic episode

- (c) psychosis

- (d) only hypomania

**Answer: (a)** — Never mania.

**Q3.** A manic episode must last at least

- (a) 1 week, unless hospitalisation is needed

- (b) 4 days

- (c) 2 weeks

- (d) 1 month

**Answer: (a)** — Plus ≥ 3 symptoms.

**Q4.** If mood is only irritable (not elevated), a manic episode needs at least

- (a) 3

- (b) 4 additional symptoms

- (c) 2

- (d) 1

**Answer: (b)** — Otherwise 3.

**Q5.** A man sleeps 2 hours a night yet feels energetic, talks non-stop, makes grandiose claims and has spent his savings on a buying spree, for over a week. The most likely diagnosis is

- (a) hypomania

- (b) schizophrenia

- (c) manic episode (bipolar I)

- (d) ADHD

**Answer: (c)** — Decreased need for sleep, grandiosity, sprees.

**Q6.** Hypomania differs from mania in that hypomania

- (a) needs hospitalisation

- (b) always has psychosis

- (c) lasts longer

- (d) lasts ≥ 4 days without psychosis, marked impairment or admission

**Answer: (d)** — Can even be adaptive.

**Q7.** More than 2 years of subthreshold hypomanic and depressive periods describes

- (a) borderline personality

- (b) persistent depressive disorder

- (c) bipolar II

- (d) cyclothymic disorder

**Answer: (d)** — Never full criteria.

**Q8.** Which can cause secondary (drug- or medical-induced) mania?

- (a) beta-blockers

- (b) anaemia

- (c) hypothyroidism

- (d) corticosteroids or hyperthyroidism

**Answer: (d)** — Also stimulants, dopamine agonists, phaeochromocytoma.

**Q9.** The proportion of people with bipolar disorder who die by suicide is about

- (a) 50%

- (b) 15–20%

- (c) 1%

- (d) 0.1%

**Answer: (b)** — 20–60 times the general population.

**Q10.** Rapid-cycling bipolar disorder means

- (a) episodes only in winter

- (b) episodes lasting < 1 day

- (c) ≥ 1 episode a year

- (d) ≥ 4 mood episodes a year

**Answer: (d)** — Predicts relapse.

**Q11.** A severely manic, psychotic patient is dangerous on the ward. Immediate control usually needs

- (a) a sedating second-generation antipsychotic, ± lorazepam

- (b) lithium alone

- (c) ECT immediately

- (d) an SSRI

**Answer: (a)** — Lithium is slow.

**Q12.** Lithium alone is not enough for acute mania because it

- (a) takes 4–10 days to work

- (b) has no effect on mania

- (c) causes mania

- (d) is only for depression

**Answer: (a)** — Add an antipsychotic or antiseizure drug.

**Q13.** First-line treatment for acute bipolar II depression is

- (a) haloperidol

- (b) valproate alone

- (c) an SSRI alone

- (d) quetiapine

**Answer: (d)** — Per MSD.

**Q14.** Antidepressants in bipolar depression are

- (a) not recommended as sole therapy

- (b) used only in mania

- (c) first line alone

- (d) contraindicated with any mood stabiliser

**Answer: (a)** — Risk of switch.

**Q15.** After remission, maintenance mood-stabiliser therapy is indicated for

- (a) only those with 3 episodes

- (b) all patients with bipolar I

- (c) only women

- (d) no one

**Answer: (b)** — Including antipsychotics.

**Q16.** The target serum lithium level in acute mania is

- (a) 0.1–0.3 mEq/L

- (b) 0.8–1.2 mEq/L

- (c) 2.0–3.0 mEq/L

- (d) 5 mEq/L

**Answer: (b)** — Narrow window.

**Q17.** Lithium toxicity occurs at concentrations of about

- (a) any level

- (b) 0.8 mEq/L

- (c) 0.5 mEq/L

- (d) 1.5 mEq/L or more

**Answer: (d)** — Close to the therapeutic range.

**Q18.** A patient on lithium develops gross tremor, brisk reflexes, vomiting and confusion. This suggests

- (a) hypothyroidism

- (b) lithium toxicity

- (c) a manic relapse

- (d) NMS

**Answer: (b)** — May progress to seizures and arrhythmias.

**Q19.** A patient stable on lithium is started on hydrochlorothiazide for hypertension. The risk is

- (a) no interaction

- (b) lower lithium levels

- (c) raised lithium levels and toxicity

- (d) hyperkalaemia only

**Answer: (c)** — Also ACE inhibitors, NSAIDs.

**Q20.** Which situation makes lithium toxicity more likely?

- (a) young age

- (b) good renal function

- (c) vomiting and diarrhoea causing sodium loss

- (d) high salt diet

**Answer: (c)** — Also fever, diuretics, old age.

**Q21.** Common early adverse effects of lithium include

- (a) priapism

- (b) hirsutism

- (c) agranulocytosis

- (d) fine tremor, polyuria, polydipsia, nausea and weight gain

**Answer: (d)** — Atenolol for severe tremor.

**Q22.** Long-term lithium can cause

- (a) hyperkalaemia

- (b) hypothyroidism, hypercalcaemia and renal damage

- (c) liver failure

- (d) hyperthyroidism only

**Answer: (b)** — Monitor TSH, calcium, renal function.

**Q23.** Lithium may worsen which skin conditions?

- (a) urticaria

- (b) acne and psoriasis

- (c) vitiligo

- (d) scabies

**Answer: (b)** — Per MSD.

**Q24.** Serum lithium in a stable patient should be checked

- (a) every 6 months and after any dose change

- (b) daily

- (c) every 5 years

- (d) only once

**Answer: (a)** — TSH before starting.

**Q25.** A rare but serious adverse effect of valproate is

- (a) Ebstein anomaly

- (b) nephrogenic diabetes insipidus

- (c) hepatotoxicity or pancreatitis

- (d) agranulocytosis

**Answer: (c)** — Wider window than lithium.

**Q26.** The mood stabiliser to avoid in all pregnant women because of a 1–4% risk of neural tube defects is

- (a) quetiapine

- (b) valproate

- (c) lamotrigine

- (d) lithium

**Answer: (b)** — Most teratogenic.

**Q27.** Lithium exposure in the first trimester is associated with

- (a) neural tube defects

- (b) cleft lip only

- (c) Ebstein anomaly

- (d) limb defects

**Answer: (c)** — Low absolute risk; detailed scan.

**Q28.** A patient started on lamotrigine with a fast dose escalation develops fever, rash and mouth ulcers. Fear

- (a) serotonin syndrome

- (b) Stevens–Johnson syndrome

- (c) NMS

- (d) lithium toxicity

**Answer: (b)** — Titrate slowly.

**Q29.** Lamotrigine is particularly useful for

- (a) acute severe mania

- (b) alcohol withdrawal

- (c) bipolar depression and cycling

- (d) NMS

**Answer: (c)** — Low teratogenic risk.

**Q30.** Lithium response is more likely in patients with

- (a) mixed episodes

- (b) a family history of typical bipolar disorder

- (c) substance use

- (d) rapid cycling

**Answer: (b)** — Others predict relapse.

### Active Recall

From memory: define bipolar I, bipolar II and cyclothymia and the criteria for mania and hypomania, outline treatment of mania and bipolar depression, and describe lithium levels, toxicity, interactions and monitoring plus the risks of other mood stabilisers in pregnancy.
